News & Updates
Filter by Specialty:
Sotorasib improves PFS over docetaxel in KRASG12C-mutated advanced NSCLC
The first-in-class KRASG12C inhibitor sotorasib significantly improved progression-free survival (PFS) in patients with previously treated non-small cell lung cancer (NSCLC) with KRASG12C mutations, according to results of the phase III CodeBreaK 200 trial presented at ESMO 2022.
Sotorasib improves PFS over docetaxel in KRASG12C-mutated advanced NSCLC
15 Dec 2022
Oral testosterone undecanoate safe, effective in hypogonadal men
Long-term treatment with an oral testosterone undecanoate (TU) formulation improves clinical outcomes in men with hypogonadism with no serious safety concerns, a study has shown.
Oral testosterone undecanoate safe, effective in hypogonadal men
15 Dec 2022
Uric acid not linked to major depressive disorder
There appears to be no significant association between serum uric acid (SUA) and major depressive disorder (MDD), suggest the results of a meta-analysis and two-sample bidirectional Mendelian randomization (MR) study.
Uric acid not linked to major depressive disorder
15 Dec 2022
COVID-19 vaccination boosts mental wellbeing during pandemic
Individuals who have received one or two doses of the COVID-19 vaccinations experience improved mental wellbeing during the pandemic, reports a recent Japan study.
COVID-19 vaccination boosts mental wellbeing during pandemic
15 Dec 2022
Coexisting diabetes ups risk of secondary malignancy, death in cancer patients
In cancer patients, the presence of diabetes appears to aggravate the likelihood of developing a secondary malignancy or death, reports a recent Japan study.